| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb61c9c83fe09226f22cd7b8a34afee4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
| filingDate |
2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da190eba8ffb75ee41693ad197b2139e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f4f3a8a2a14df9883bdbe4f93cb3008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce7abd4407e1f9704734ece3de5e7cf |
| publicationDate |
2015-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2928458-A1 |
| titleOfInvention |
Spermidine/spermine n'-acetyltransferase substrates as anti-cancer drug compounds |
| abstract |
ABSTRACT OF THE DISCLOSURE An anti-cancer drug compound comprises an spermidine/spermine N -acetyltransferase substrate. The spermidine/spermine N -acetyltransferase substrate may be a monoamine. The spermidine/spermine N -acetyltransferase substrate may be amantadine, rimantadine, dopamine or L-DOPA. A method of treating cancer comprises the use of an spermidine/spermine N -acetyltransferase substrate to treat cancer. The spermidine/spermine N -acetyltransferase substrate may be a monoamine. The spermidine/spermine N -acetyltransferase substrate may be amantadine, rimantadine, dopamine or L-DOPA. |
| priorityDate |
2012-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |